# Safety, Pharmacokinetics and Pharmacodynamics of BIRT 1696 BS in Healthy Human Subjects

> **NCT02254096** · PHASE1 · COMPLETED · sponsor: **Boehringer Ingelheim** · enrollment: 46 (actual)

## Conditions studied

- Healthy

## Interventions

- **DRUG:** BIRT 1696 BS
- **DRUG:** Placebo
- **OTHER:** Grapefruit juice (GFJ)
- **OTHER:** High fat meal (HFM)

## Key facts

- **NCT ID:** NCT02254096
- **Lead sponsor:** Boehringer Ingelheim
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2002-05
- **Primary completion:** 2002-07
- **Final completion:** —
- **Target enrollment:** 46 (ACTUAL)
- **Last updated:** 2014-10-01


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02254096

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02254096, "Safety, Pharmacokinetics and Pharmacodynamics of BIRT 1696 BS in Healthy Human Subjects". Retrieved via AI Analytics 2026-05-28 from https://api.ai-analytics.org/clinical/NCT02254096. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*